At the NSE, the stock jumped 9.34 per cent to close the day at Rs 1,166.
The pharma company's stock zoomed 8.82 per cent to close at Rs 1,159.85 on the BSE. During the day, the scrip surged 9.99 per cent to Rs 1,172.40.
"The voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden (AZP AB) in terms of their letter dated March 1, 2014 will be considered at the meeting of the board of directors of the company on March 15," AstraZeneca Pharma India had said in a filing to the BSE yesterday.
Astrazeneca Pharmaceuticals AB holds 75 per cent in AstraZeneca Pharma India.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
